Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
- 18-HEPE cPLA2i 1.0 BCD110605C16 0.149 pmol/ml of medium
- 18-HEPE cPLA2i 1.0 BCD110605C18 0.186 pmol/ml of medium
- 18-HEPE cPLA2i 1.0 BCD110605C17 0.32 pmol/ml of medium
- 18-HEPE cPLA2i 4.0 BCD110605C34 0.427 pmol/ml of medium
- 18-HEPE cPLA2i 4.0 BCD110605C36 0.292 pmol/ml of medium
- 18-HEPE cPLA2i 4.0 BCD110605C35 0.561 pmol/ml of medium
- 18-HEPE cPLA2i 20.0 BCD110605C53 0.401 pmol/ml of medium
- 18-HEPE cPLA2i 20.0 BCD110605C54 0.409 pmol/ml of medium
- 18-HEPE cPLA2i 20.0 BCD110605C52 0.765 pmol/ml of medium
- 18-HEPE PLDi 1.0 BCD110605C10 0.274 pmol/ml of medium
- 18-HEPE PLDi 1.0 BCD110605C12 0.385 pmol/ml of medium
- 18-HEPE PLDi 1.0 BCD110605C11 0.447 pmol/ml of medium
- 18-HEPE PLDi 4.0 BCD110605C30 0.276 pmol/ml of medium
- 18-HEPE PLDi 4.0 BCD110605C29 0.372 pmol/ml of medium
- 18-HEPE PLDi 4.0 BCD110605C28 0.303 pmol/ml of medium
- 18-HEPE PLDi 20.0 BCD110605C48 0.471 pmol/ml of medium
- 18-HEPE PLDi 20.0 BCD110605C47 0.625 pmol/ml of medium
- 18-HEPE PLDi 20.0 BCD110605C46 0.592 pmol/ml of medium
- 18-HEPE KDO+cPLA2i 1.0 BCD110605C19 0.266 pmol/ml of medium
- 18-HEPE KDO+cPLA2i 1.0 BCD110605C21 0.284 pmol/ml of medium
- 18-HEPE KDO+cPLA2i 1.0 BCD110605C20 0.354 pmol/ml of medium
- 18-HEPE KDO+cPLA2i 4.0 BCD110605C39 0.489 pmol/ml of medium
- 18-HEPE KDO+cPLA2i 4.0 BCD110605C37 0.878 pmol/ml of medium
- 18-HEPE KDO+cPLA2i 4.0 BCD110605C38 0.411 pmol/ml of medium
- 18-HEPE KDO+cPLA2i 20.0 BCD110605C55 0.939 pmol/ml of medium
- 18-HEPE KDO+cPLA2i 20.0 BCD110605C57 0.547 pmol/ml of medium
- 18-HEPE KDO+cPLA2i 20.0 BCD110605C56 0.511 pmol/ml of medium
- 18-HEPE KDO+PLDi 1.0 BCD110605C15 0.282 pmol/ml of medium
- 18-HEPE KDO+PLDi 1.0 BCD110605C14 0.388 pmol/ml of medium
- 18-HEPE KDO+PLDi 1.0 BCD110605C13 0.291 pmol/ml of medium
- 18-HEPE KDO+PLDi 4.0 BCD110605C32 0.477 pmol/ml of medium
- 18-HEPE KDO+PLDi 4.0 BCD110605C31 0.343 pmol/ml of medium
- 18-HEPE KDO+PLDi 4.0 BCD110605C33 0.259 pmol/ml of medium
- 18-HEPE KDO+PLDi 20.0 BCD110605C49 0.786 pmol/ml of medium
- 18-HEPE KDO+PLDi 20.0 BCD110605C51 1.07 pmol/ml of medium
- 18-HEPE KDO+PLDi 20.0 BCD110605C50 0.432 pmol/ml of medium
- 18-HEPE KDO + ATP 1.0 BCD110605C07 0.34 pmol/ml of medium
- 18-HEPE KDO + ATP 1.0 BCD110605C09 0.35 pmol/ml of medium
- 18-HEPE KDO + ATP 1.0 BCD110605C08 0.375 pmol/ml of medium
- 18-HEPE KDO + ATP 4.0 BCD110605C25 0.429 pmol/ml of medium
- 18-HEPE KDO + ATP 4.0 BCD110605C26 0.399 pmol/ml of medium
- 18-HEPE KDO + ATP 4.0 BCD110605C27 0.5 pmol/ml of medium
- 18-HEPE KDO + ATP 20.0 BCD110605C45 1.04 pmol/ml of medium
- 18-HEPE KDO + ATP 20.0 BCD110605C43 0.732 pmol/ml of medium
- 18-HEPE KDO + ATP 20.0 BCD110605C44 0.868 pmol/ml of medium
- 18-HEPE C 0.0 BCD110605C02 0.363 pmol/ml of medium
- 18-HEPE C 0.0 BCD110605C01 0.349 pmol/ml of medium
- 18-HEPE C 0.0 BCD110605C03 0.325 pmol/ml of medium
- 18-HEPE C 1.0 BCD110605C06 0.289 pmol/ml of medium
- 18-HEPE C 1.0 BCD110605C05 0.317 pmol/ml of medium